Photodynamic Therapy in Pathologic Myopia Experiences in Hungary
Papp A., Seres A., Pregun T., Szabó A., Süveges I.
1st Dept. of Ophthalmology Semmelweis University, Budapest
Purpose: To summarize the results of photodynamic treatments (PDT) performed on eyes with subretinal neovascularisations due to pathologic myopia (PM).
Method: We reviewed the case-records file of that group of this patients group focusing on the changes of visual acuity (ETDRS), the number of the required treatments and the detected side effects during the follow up period.
Results: Between april 2000 and march 2003 42 eyes of 39 myopic patients were treated with PDT in our department. We report the results of 16 consecutive patients who had more than one year follow up. At the 12 months follow up period serious decrease (more than 6 lines) in the visual acuity were detected in 1 case (6%), 2 eyes lost more than 3 lines (12%), the visual acuity remained stable in 12 eyes (75%), and improved in 5 eyes (31%). Our re-treatment ratio was lower (2.6/year) than reported by the international study group. Apart from a transient back pain during the intravenous administration of verteporfin in one case no other side effects were detected.
Conclusions: Photodynamic therapy with verteporfin is a safe method for decreasing the risk of threatening visual impairment in certain eyes with subretinal neovascularisaton related to pathologic myopia. Our results are similar with the international studies.
Zurück | Back